One HopeSolution
Back to Knowledge Centre

Market entry

How to Sequence Launch Markets So Evidence Compounds

8 min read

Launching in multiple countries at the same time sounds efficient. In practice, it can create duplicated work, different documentation requirements and unnecessary reformulation or relabelling. A better approach is often to think of market entry as a sequence.

Start With the Product

Before choosing a market, define:

  • Product category
  • Ingredients
  • Dosage form
  • Claims
  • Target consumer
  • Available evidence
  • Manufacturing location
  • Existing certifications
  • Current documentation
  • Intended commercial model

The same product may be treated differently across jurisdictions.

Choose the First Market Strategically

The first market should not necessarily be the largest market.

Consider:

  • Regulatory complexity
  • Product classification
  • Evidence requirements
  • Documentation burden
  • Language requirements
  • Registration pathway
  • Distributor capability
  • Commercial opportunity
  • Future reuse of documentation

The objective is to create useful regulatory and technical assets that can support subsequent markets where appropriate.

Build a Reusable Evidence Package

A well-organized product file may contain:

  • Product specification
  • Formula
  • Ingredient documentation
  • Certificates
  • Test reports
  • Manufacturing information
  • Stability information where applicable
  • Label and artwork
  • Claims substantiation
  • Quality documentation
  • Product information

Some elements may be reusable across markets while others will need adaptation.

Think in a Market Sequence

A possible strategy is:

  1. 01Market 1 — build and organize core documentation
  2. 02Market 2 — adapt documentation and claims
  3. 03Market 3 — reuse validated information where appropriate
  4. 04Market 4

This does not mean one approval automatically supports another. Each market must be assessed independently.

Avoid the “Same File Everywhere” Trap

A common mistake is assuming that a dossier prepared for one country can simply be submitted unchanged elsewhere.

Country-specific differences can include:

  • Product classification
  • Permitted ingredients
  • Maximum levels
  • Claims
  • Labelling
  • Testing
  • Certificates
  • Responsible parties
  • Registration procedures

The objective is therefore not document duplication. It is intelligent document reuse with country-specific adaptation.

Conclusion

International expansion becomes more manageable when each market is treated as part of a broader product strategy.

The right question is not “Which country should we enter first?” It is “Which market should we enter first so that the work we do today creates value for the markets we want to enter tomorrow?”

Planning international expansion?

Tell us the product and the markets on your roadmap. We will propose a sequence that lets the documentation you build carry forward.

Discuss Your Requirement

General information only. Regulatory requirements vary by product, jurisdiction and intended use. This article does not constitute legal or regulatory advice for a specific product.